Android app on Google Play

AVEO Pharmaceuticals (AVEO) Prices Offering at $7.50/Sh

January 17, 2013 9:16 AM EST Send to a Friend
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) announced the pricing of an underwritten public offering of 6,667,000 shares of its common stock at a price of $7.50 per share to the public.

All of the shares are being sold by AVEO.

The gross proceeds to AVEO from this offering are expected to be approximately $50.0 million, before deducting underwriting discounts and commissions, and other estimated offering expenses payable by AVEO.

J.P. Morgan Securities LLC is acting as sole book-running manager for the offering, with RBC Capital Markets, LLC and Canaccord Genuity Inc. acting as co-lead managers.

You May Also Be Interested In

Related Categories

Equity Offerings

Related Entities

JPMorgan, RBC Capital, Canaccord Genuity

Add Your Comment